ESC 365 - Survival with aortic valve replacement in asymptomatic individuals with severe aortic stenosis and LVEF 50-54%

ESC2025 Premium Access

Survival with aortic valve replacement in asymptomatic individuals with severe aortic stenosis and LVEF 50-54%

Session: New perspectives in cardiology (3) - Treatment of aortic stenosis and TAVI

Topic: Aortic Valve Intervention

Speaker: Associate Professor J. Wasfy (Boston, US)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Associate Professor Jason Wasfy

Massachusetts General Hospital - Harvard Medical School, Boston (United States of America)

0 follower

10 more presentations in this session

Discussant - Treatment of aortic stenosis and TAVI

The effects of surgical and transcatheter aortic valve replacement for aortic stenosis on regression and progression of mitral regurgitation -a propensity score matched analysis

Speaker: Doctor S. Kazum (Petah Tikva, IL)

Sex-related differences in reverse cardiac remodeling after transcatheter aortic valve replacement: focus on the right side of the heart

Speaker: Doctor C. Olmos (Madrid, ES)

Quality-of-life improvement of the 100 patients treated over the Valvosoft prospective, multi-centre, single-arm first-in-human and pivotal studies: 12 month follow-up.

Speaker: Professor E. Messas (Paris, FR)

Transcatheter aortic valve implantation without cardiac surgery backup: single-center experience assessing safety and efficacy outcomes

Speaker: Mr A. Rocha De Almeida (Evora, PT)

Access the full session

New perspectives in cardiology (3) - Treatment of aortic stenosis and TAVI

Speakers: Associate Professor J. Wasfy, Doctor S. Kazum, Doctor C. Olmos, Professor E. Messas, Mr A. Rocha De Almeida

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources